Sigma Planning Corp’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.9K | Sell |
55,500
-270,760
| -83% | -$185K | ﹤0.01% | 1231 |
|
|
2025
Q1 | $297K | Sell |
326,260
-120,915
| -27% | -$110K | 0.01% | 950 |
|
|
2024
Q4 | $487K | Buy |
447,175
+45,850
| +11% | +$50K | 0.02% | 752 |
|
|
2024
Q3 | $304K | Buy |
401,325
+135,295
| +51% | +$102K | 0.01% | 945 |
|
|
2024
Q2 | $330K | Buy |
266,030
+10,025
| +4% | +$12.4K | 0.01% | 884 |
|
|
2024
Q1 | $484K | Buy |
256,005
+147,130
| +135% | +$278K | 0.02% | 776 |
|
|
2023
Q4 | $287K | Sell |
108,875
-135,830
| -56% | -$359K | 0.02% | 634 |
|
|
2023
Q3 | $563K | Buy |
244,705
+19,405
| +9% | +$44.6K | 0.02% | 660 |
|
|
2023
Q2 | $822K | Buy |
225,300
+4,411
| +2% | +$16.1K | 0.03% | 538 |
|
|
2023
Q1 | $789K | Buy |
220,889
+28,155
| +15% | +$101K | 0.03% | 610 |
|
|
2022
Q4 | $549K | Buy |
192,734
+4,310
| +2% | +$12.3K | 0.02% | 729 |
|
|
2022
Q3 | $420K | Buy |
188,424
+21,318
| +13% | +$47.5K | 0.02% | 800 |
|
|
2022
Q2 | $416K | Buy |
167,106
+37,378
| +29% | +$93.1K | 0.01% | 825 |
|
|
2022
Q1 | $633K | Buy |
129,728
+43,835
| +51% | +$214K | 0.02% | 736 |
|
|
2021
Q4 | $971K | Buy |
85,893
+1,650
| +2% | +$18.7K | 0.03% | 553 |
|
|
2021
Q3 | $1.23M | Buy |
84,243
+2,542
| +3% | +$37K | 0.04% | 471 |
|
|
2021
Q2 | $952K | Buy |
81,701
+8,613
| +12% | +$100K | 0.03% | 565 |
|
|
2021
Q1 | $892K | Buy |
73,088
+1,512
| +2% | +$18.5K | 0.03% | 545 |
|
|
2020
Q4 | $895K | Buy |
71,576
+11,753
| +20% | +$147K | 0.03% | 467 |
|
|
2020
Q3 | $900K | Buy |
59,823
+6,744
| +13% | +$101K | 0.04% | 424 |
|
|
2020
Q2 | $1.3M | Sell |
53,079
-13,166
| -20% | -$323K | 0.06% | 321 |
|
|
2020
Q1 | $940K | Buy |
66,245
+885
| +1% | +$12.6K | 0.06% | 332 |
|
|
2019
Q4 | $1.04M | Buy |
65,360
+5,150
| +9% | +$81.8K | 0.04% | 392 |
|
|
2019
Q3 | $508K | Buy |
60,210
+12,405
| +26% | +$105K | 0.02% | 561 |
|
|
2019
Q2 | $430K | Buy |
47,805
+5,706
| +14% | +$51.3K | 0.02% | 594 |
|
|
2019
Q1 | $325K | Buy |
+42,099
| New | +$325K | 0.02% | 642 |
|